• Levemir^®
  (insulin detemir [rDNA origin] injection)
• NovoLog^®
  (insulin aspart [rDNA origin] injection)
• NovoLog^® Mix 70/30
  (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin])

ABOUT THE EXHIBIT

The faces you see around you represent the more than 21 million children and adults in the United States living with type 2 diabetes every day of their lives. Type 2 diabetes accounts for about 90 to 95 percent of all diagnosed cases of diabetes. This showcase honors those who have successfully made changes to adapt and persevere while living with the disease.

Meet the Face of Change™ is a traveling photo exhibit. Each photo here represents a person living with type 2 diabetes. All of them have their own story of how they have embraced change and taken charge of their diabetes and their life.

Rick Smolan, a former National Geographic photographer and creator of the best-selling "Day in the Life" photography series, produced this exhibit as a way of sharing the stories of the faces in these portraits to highlight how people with diabetes can not only manage but can continue living their lives to the fullest. This exhibit serves as an example of the challenges and triumphs of people living with diabetes, especially as the disease continues to affect an ever increasing number of Americans.

About Diabetes

Diabetes is a serious, chronic disease in which the body does not produce or properly use insulin, a hormone needed to convert sugar, starches, and other food into energy needed for daily life. People with type 1 diabetes do not produce insulin and must take it on a daily basis. People with type 2 diabetes either are unable to properly use the insulin their bodies produce or do not make enough to meet their body's needs.

While many people can control their type 2 diabetes with diet and exercise by losing excess weight and taking medication, the majority–even if they follow their treatment—will eventually need insulin therapy, and there are often fears of insulin treatment.

Why Change?

People with type 2 diabetes face constant change–whether transitioning to a healthy diet, starting or maintaining an exercise plan, or altering their medication as their diabetes progresses.

Meet the Face of Change™ showcases everyday people who have overcome these barriers, providing an example that managing diabetes is both possible and practical. It is sponsored by the Novo Nordisk portfolio of insulins.

Levemir® [insulin detemir (rDNA origin) injection]

Levemir® is used to treat patients with diabetes for the control of high blood sugar.
It's used once or twice a day to lower blood sugar.

Important Safety Information

Levemir® should not be diluted or mixed with any other insulin or solution.

People who are allergic to insulin or the other ingredients in Levemir® should not take Levemir®.

Insulins, including Levemir®, can cause low blood sugar (hypoglycemia). This is the most common side effect. You must test your blood sugar while using an insulin, such as Levemir®.

If you test your blood sugar and it is too low, you should not take Levemir®. Ask your doctor how often you should test your blood sugar, and what to do if it is high or low. Drinking alcohol may also increase the risk of low blood sugar.

Do not change the insulin you are using without talking to your doctor. Doses of oral antidiabetic medicines may also need to change. Your insulin needs may change due to a number of factors, such as illness, stress, medicines, and changes in diet or exercise routines.

Before starting Levemir®, tell your doctor about all your medical conditions including if you have liver or kidney problems, are pregnant or planning to become pregnant, are breast-feeding or planning to breast-feed, or take any other medicines. Do not start any new medicines until you know how they may affect your insulin dose.

When you take Levemir®, you may notice some side effects common to insulin. These include low or high blood sugar, reaction at the injection site (like redness, swelling, and itching) and allergic reactions. Get medical help right away if you experience signs of serious allergic reaction such as body rash, trouble with your breathing, fast heartbeat or sweating. Ask your doctor or pharmacist for further information.

NovoLog® [insulin aspart (rDNA origin) injection]

NovoLog® is a man-made insulin that is used to control high blood sugar in adults and children with diabetes mellitus.

Important Safety Information

NovoLog® is a fast-acting insulin. You should eat a meal within 5 to 10 minutes after using NovoLog® to avoid low blood sugar. Do not inject NovoLog® if you do not plan to eat right after using NovoLog®. Check your blood sugar levels. Ask your health care provider what your blood sugars should be and when you should check your blood sugar levels. Alcohol, including beer and wine, may affect your blood sugar when you take NovoLog®.

Do not change the type of insulin you use unless told to do so by your health care provider. The amount of insulin you take as well as the best time for you to take your insulin may need to change if you take a different type of insulin.

Do not mix NovoLog® with any other insulins when used in a pump or with any insulins other than NPH when used with injections by syringe.

Do not take NovoLog® if your blood sugar is too low (hypoglycemia) or if you are allergic to anything in NovoLog®. If you take too much NovoLog® your blood sugar may fall too low.

Tell your health care provider about all medicines you take and all of your medical conditions, including if you are pregnant or breastfeeding. Your NovoLog® dose may change if you take other medicines.

The most common side effect of insulin therapy, including NovoLog® is low blood sugar (hypoglycemia). Other possible side effects include reactions at the injection site (like redness, swelling and itching), and allergic reactions. Get medical help right away if you experience signs of serious allergic reaction such as body rash, trouble with your breathing, fast heartbeat, or sweating. Ask your doctor or pharmacist for further information.

NovoLog® Mix 70/30 [70% insulin aspart protamine suspension and 30% insulin aspart injection, (rDNA origin)]

NovoLog® Mix 70/30 is for use in patients with diabetes to control high blood glucose.

Important Safety Information

You should know that NovoLog® Mix 70/30 is different from other insulin mixtures because it works fast. So it's important to take your dose within 15 minutes of a meal. Also, check your blood glucose regularly. Do not use NovoLog® Mix 70/30 if your blood glucose is too low or if you are allergic to this medication. Low blood glucose is the most common side effect. If you have been taking another type of insulin, the time at which low blood glucose could occur may be different. Any change in insulin should be made cautiously and only under medical supervision.

FlexPen®, Levemir®, and NovoLog® are registered trademarks of Novo Nordisk A/S.
© 2008 Novo Nordisk Inc. 135082
Privacy Policy | Contact Us